Staphefekt, developed by the Dutch biotechnology company Micreos, is the world's first bacteria-killing enzyme targeting the Staphylococcus aureus-bacteria. It is available in Gladskin creams and gels for people with skin problems.
Scientists create drug to replace antibiotics
Share this article
Bekijk een volgend artikel
An alternative approach to antibiotics
BBC Two Trust Me I'm a Doctor features Gladskin technology